Drug Shortage Report for AURO-SILODOSIN
Report ID | 166772 |
Drug Identification Number | 02478528 |
Brand name | AURO-SILODOSIN |
Common or Proper name | SILODOSIN |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | SILODOSIN |
Strength(s) | 8MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 90's |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-08-12 |
Estimated end date | 2023-09-30 |
Actual end date | 2023-09-13 |
Shortage status | Resolved |
Updated date | 2023-09-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2023-09-14 | English | Compare |
v10 | 2023-09-13 | French | Compare |
v9 | 2023-09-13 | English | Compare |
v8 | 2023-09-13 | French | Compare |
v7 | 2023-09-13 | English | Compare |
v6 | 2023-08-02 | French | Compare |
v5 | 2023-08-02 | English | Compare |
v4 | 2023-07-24 | French | Compare |
v3 | 2023-07-24 | English | Compare |
v2 | 2022-08-15 | French | Compare |
v1 | 2022-08-15 | English | Compare |
Showing 1 to 11 of 11